AlphAIAlphAI — Financial news for AI agents
stocktitan.netSEP 11 min read$FUL

H.B. Fuller (FUL) director granted 488 stock units in pay plan

H.B. Fuller (FUL) director Michael J. Happe received 488 stock units worth $56.35 each on August 28, 2026, under a directors' compensation plan. These units convert to common stock 1:1 upon certain events. Happe now holds 18,329 stock units and 1,343 shares directly.

Original reporting
stocktitan.net
Published Sep 1, 2026, 4:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 11:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$FUL
Neutral
high confidence
Mentioned
$FUL
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$FULNeutralLow
01

Why it matters

Limited impact on share count and price; primarily informational for governance monitoring.

02

Market read

Minor insider transaction with negligible market effect.

03

What to watch

Potential future conversion of units upon retirement or death could slightly increase float over the long term.

Relevance 4/10Novelty 4/10Timing: post filing August 28 2026

Background

Form 4 filing discloses insider compensation; such grants are routine for directors.

Company-level read

Ticker impact

$FULNeutralHigh confidence
Context

Director Michael J. Happe was granted 488 stock units at $56.35 per unit, a new Form 4 filing disclosed on August 28 2026.

Expected impact

minimal to none

Evidence & confidence

Small insider grant to a director does not materially affect supply or investor perception.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

The grant could be seen as a confidence signal, but the size is too small to influence the stock.

Key entities

  • Director
    Michael J. Happe

    Recipient of the stock unit grant.

  • Company
    H.B. Fuller Co.

    Issuer of the stock units.

Read at source← All news

Related articles

AUG 24
$FULMedAI 8/10

H.B. Fuller board rejects unsolicited bid

H.B. Fuller's board rejected an unsolicited bid for its BAS segment, citing a valuation below market precedent and lack of financing details. The board highlighted BAS's 6% organic growth and 10% EBITDA improvement, noting its importance for future earnings. The board also cited operational integration challenges and reaffirmed its strategic priorities, including the Advanced Medical Solutions acquisition and Project Quantum Leap.

european-coatings.com1 min
AUG 24
$FULMedAI 8/10

H.B. Fuller stock flat as board rejects Ancora’s adhesives bid

H.B. Fuller Co. (NYSE:FUL) shares were unchanged in premarket trading after its board rejected Ancora Holdings Group's $1.2 billion bid for its building adhesives unit, citing undervaluation and lack of growth potential consideration. Ancora criticized the rejection as irrational and emphasized its ability to finance a higher offer. The bid aimed to help H.B. Fuller reduce debt and focus on integrating Advanced Medical Solutions Group Plc.

investing.com1 min
AUG 13
$FULMed

AMS shareholders approve H.B. Fuller acquisition proposal

H.B. Fuller (NYSE:FUL) said Advanced Medical Solutions Group plc (LSE:AMS) shareholders approved the proposed cash acquisition of AMS. The approval is a milestone toward closing, which H.B. Fuller expects by year end, subject to remaining conditions and regulatory approvals. H.B. Fuller reported 2025 revenue of $3.5B.

investing.com2 min
AUG 12
$FULMed

Ancora offers up to $1.2bn for an H.B. Fuller business

Activist investor Ancora Holdings proposes an all-cash offer of up to $1.2bn to buy H.B. Fuller’s Building Adhesive Solutions unit, urging divestiture and offering to start due diligence. Ancora, holding over 2% of shares, says it has received no substantive response and may seek board control via a proxy fight. H.B. Fuller shares were down 2.3% intraday.

marketscreener.com4 min